Abstract and Introduction Current Status of DILI Biomarkers Promising Avenues for Discovery of New DILI Biomarkers Next Steps References The lymphocyte transformation test is commercially ...

Biomarkers are traits that doctors measure in your blood, body fluids, and tissues. Experts also call them molecular markers and signature molecules. They can be signs of conditions, diseases ...

Doctors use biomarkers to assess a person's health, diagnose and monitor disease progression, and determine how a person's body is responding to treatment. Learn more.

CAMBRIDGE, England, June 10, 2025--CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal ...

"GLDH will allow drug developers to properly determine the onset of liver injury in clinical trials for novel therapies to treat patients with muscle disease, where the traditional DILI biomarkers may ...

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), drug-induced liver injury (DILI) is the leading cause of acute liver failure in the U.S. It is also a leading ...

From simple physiological measurements and small molecules to imaging and histologic information, biomarkers found within the human body reveal valuable insights into health and disease. These key ...

In response to growing market demand for tools that address these concerns, CN Bio has expanded the in vitro to in vivo extrapolation (IVIVE) capabilities of its established PhysioMimix ® DILI ...